Christos Apostolidis Selected Research

Christos Apostolidis Research Topics

Disease

24	Neoplasms (Cancer) 12/2021 - 05/2003
9	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 04/2006
4	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 06/2006
4	Neoplasm Micrometastasis 12/2009 - 12/2006
3	Brain Neoplasms (Brain Tumor) 01/2020 - 01/2018
3	Melanoma (Melanoma, Malignant) 09/2011 - 06/2007
3	Stomach Neoplasms (Stomach Cancer) 02/2010 - 05/2003
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2020 - 01/2018
2	Leukemia 01/2020 - 03/2007
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020 - 01/2018
2	Glioma (Gliomas) 01/2018 - 06/2006
2	Communicable Diseases (Infectious Diseases) 07/2012 - 05/2006
2	Neoplasm Metastasis (Metastasis) 09/2011 - 12/2009
2	Breast Neoplasms (Breast Cancer) 12/2009 - 05/2003
2	Ovarian Neoplasms (Ovarian Cancer) 01/2008 - 03/2006
1	Carcinoma in Situ 01/2018
1	Edema (Dropsy) 01/2018
1	Headache (Headaches) 01/2018
1	Holt-Oram syndrome 01/2014
1	Lymphatic Metastasis 02/2009
1	Necrosis 02/2009
1	Ascites 01/2008
1	Peritoneal Neoplasms 06/2007
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 11/2006
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 08/2006
1	Mycoses (Diseases, Fungus) 05/2006
1	Bacterial Infections (Bacterial Infection) 05/2006
1	Multiple Myeloma 10/2005
1	Lymphoma (Lymphomas) 11/2004
1	Chromosomal Instability (Chromosome Stability) 10/2003
1	Carcinoma (Carcinomatosis) 09/2003

Drug/Important Bio-Agent (IBA)

9	Monoclonal AntibodiesIBA 09/2011 - 09/2003
8	AntigensIBA 10/2017 - 05/2003
7	Radioisotopes (Radionuclides)IBA 01/2020 - 03/2006
5	Immunoconjugates (Immunoconjugate)IBA 01/2018 - 05/2003
4	Bismuth-213IBA 01/2008 - 05/2003
3	Substance PIBA 01/2019 - 06/2006
3	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2019 - 01/2018
3	AntibodiesIBA 03/2007 - 09/2003
3	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2007 - 10/2005
2	LigandsIBA 01/2019 - 01/2018
2	3-O-(methylthiomethyl)apiitol tetraacetateIBA 02/2009 - 12/2006
2	Proteins (Proteins, Gene)FDA Link 06/2007 - 05/2003
1	Somatostatin Receptors (Somatostatin Receptor)IBA 12/2021
1	ErbB Receptors (EGF Receptor)IBA 01/2018
1	NeuropeptidesIBA 01/2018
1	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 01/2018
1	gallium 68 PSMA-11IBA 12/2016
1	antineoplaston A10 (A 10)IBA 01/2014
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 09/2011
1	Plasminogen Activators (Plasminogen Activator)IBA 02/2009
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 02/2009
1	Bevacizumab (Avastin)FDA Link 10/2008
1	Mucin-1 (CA 15-3 Antigen)IBA 01/2008
1	Tumor Biomarkers (Tumor Markers)IBA 06/2007
1	Firefly LuciferasesIBA 06/2007
1	Caspase 9IBA 03/2007
1	Fas Ligand Protein (Fas Ligand)IBA 03/2007
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 03/2007
1	Caspase 3 (Caspase-3)IBA 03/2007
1	Caspase 8 (Caspase-8)IBA 03/2007
1	fludarabineIBA 08/2006
1	Colchicine FDA LinkGeneric 08/2006
1	Cisplatin (Platino)FDA LinkGeneric 08/2006
1	Vincristine (Oncovin)FDA LinkGeneric 08/2006
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 08/2006
1	Simvastatin (Zocor)FDA LinkGeneric 08/2006
1	AcidsIBA 06/2006
1	Plasminogen InactivatorsIBA 04/2006
1	Trastuzumab (Herceptin)FDA Link 03/2006
1	Syndecan-1 (Syndecan 1)IBA 10/2005
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2005
1	Rituximab (Mabthera)FDA Link 11/2004
1	Dihydrotachysterol (AT 10)IBA 10/2003
1	Cadherins (E-Cadherin)IBA 05/2003
1	Terbium-149IBA 05/2003

Therapy/Procedure

22	Therapeutics 01/2020 - 09/2003
9	Radioimmunotherapy 12/2009 - 09/2003
8	Radiotherapy 01/2018 - 10/2003
3	Castration 01/2018 - 12/2016
2	Drug Therapy (Chemotherapy) 01/2018 - 08/2006
1	Cystectomy 01/2018
1	Aftercare (After-Treatment) 08/2006
1	Brachytherapy 06/2006